kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the SABS dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for SABS.

SABS

SAB Biotherapeutics, Inc.
Healthcare · Biotechnology
$229.50 sample
-0.87 (-0.38%) 1D
☆ Watch
Market cap
$826.8B
Price as of
2026-10-29
Latest filing
8-K · 2026-09-17
Alerts
8
Price$229.50 +9.02% 3M daily closessample
230.37207.74
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 22INSInsider sell: 10% owner
  • Oct 19INSInsider buy: EVP, Operations
  • Oct 09INSInsider buy: Chief Financial Officer
  • Oct 06INSInsider buy: EVP, Operations
  • Sep 29INSInsider sell: Chief Financial Officer
  • Sep 23INSInsider sell: General Counsel
  • Sep 17SEC8-K filed: material event
  • Sep 10INSInsider buy: EVP, Operations
Sign up to see the real SABS record →

Company facts

SEC EDGAR registration
Name
SAB Biotherapeutics, Inc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
+51sample, -100 to +100
Reporting currency
USD

Who is positioning in SABS

sample
Insiders
7 insider transactions over 90 days, net selling, $322.4M
Congress
4 members traded over 90 days
Institutions · 13F
36 funds hold $10.4B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$29.1B +21.2% y/y
Q4 2024Q3 2026
Inventory$16.9B +14.1% y/y
Q4 2024Q3 2026
Accounts receivable$13.0B +18.1% y/y
Q4 2024Q3 2026
Total debt$33.9B +13.5% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$404.7B -9.7% 3M
Sample peer B
$599.3B +14.7% 3M
Sample peer C
$812.1B -11.0% 3M
Sample peer D
$588.6B +11.3% 3M
Sample peer E
$720.7B -6.7% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not SABS's real figure. Nothing here is investment advice.